Boston Scientific Treasury Stock, Value remained flat by 0.0% to $2.25B in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.25B to $2.25B. Over 5 years (FY 2020 to FY 2025), Treasury Stock, Value shows relatively stable performance with a 0.0% CAGR.
An increase indicates active share buyback programs, which often signal management's confidence in the company's valuation.
This represents the value of shares that the company has repurchased from the open market and holds in its own treasury....
Common for mature companies with excess cash flow looking to improve earnings per share.
equity_treasury_stock_value| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |